Ifp Advisors, Inc Emergent Bio Solutions Inc. Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$11.0 - $21.45 $1,925 - $3,753	-175 Reduced 84.13%	33 $9,000
Q3 2022 Nov 08, 2022	SELL	$20.09 - $35.8 $1,285 - $2,291	-64 Reduced 23.53%	208 $19,000
Q2 2022 Sep 06, 2022	BUY	$27.42 - $43.63 $7,458 - $11,867	272 New	272 $22,000
Q2 2022 Aug 12, 2022	SELL	$27.42 - $43.63 $7,458 - $11,867	-272 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$36.48 - $52.22 $9,375 - $13,420	257 Added 1713.33%	272 $11,000
Q3 2021 Oct 06, 2021	SELL	$50.07 - $66.05 $13,568 - $17,899	-271 Reduced 94.76%	15 $1,000
Q2 2021 Jul 13, 2021	BUY	$56.61 - $80.46 $7,755 - $11,023	137 Added 91.95%	286 $19,000
Q1 2021 Apr 30, 2021	SELL	$86.23 - $125.19 $20,005 - $29,044	-232 Reduced 60.89%	149 $13,000
Q4 2020 Jan 25, 2021	BUY	$79.17 - $111.47 $6,729 - $9,474	85 Added 28.72%	381 $34,000
Q3 2020 Oct 29, 2020	BUY	$81.91 - $134.94 $20,805 - $34,274	254 Added 604.76%	296 $31,000
Q1 2020 May 12, 2020	SELL	$49.34 - $68.76 $493 - $687	-10 Reduced 19.23%	42 $3,000
Q3 2019 Nov 07, 2019	BUY	$40.6 - $57.2 $2,111 - $2,974	52 New	52 $3,000
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $9,887 - $13,562	-205 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$55.63 - $73.24 $111 - $146	-2 Reduced 0.97%	205 $12,000
Q3 2018 Oct 25, 2018	BUY	$52.05 - $66.51 $3,591 - $4,589	69 Added 50.0%	207 $0
Q2 2018 Aug 07, 2018	BUY	$48.33 - $55.64 $5,171 - $5,953	107 Added 345.16%	138 $0
Q1 2018 Jun 03, 2019	SELL	$44.44 - $54.39 $4,399 - $5,384	-99 Reduced 76.15%	31 $1,000
Q1 2018 May 09, 2018	BUY	$44.44 - $54.39 $4,399 - $5,384	99 Added 319.35%	130 $0
Q4 2016 Jun 03, 2019	SELL	N/A	-309 Reduced 90.88%	31 $1,000
Q2 2016 Jun 03, 2019	BUY	N/A	340	340 $10,000

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account